Daniel Gaudet, Université de Montréal, Quebec, Canada, discusses recent results from the SHASTA-2 and MUIR studies of plozasiran and looks ahead at the ongoing PALISADE study and the SHASTA-3 and SHASTA-4 studies.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
